Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Contract Wins and Trading Update

4 Mar 2014 07:00

RNS Number : 4149B
Ideagen PLC
04 March 2014
 



 

Ideagen plc

("Ideagen" or the "Group")

 

Contract Wins and Trading Update

 

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, announces that trading in the second half of the current financial year has continued strongly with a significant increase in contract wins from the commercial sector.

 

Contract Wins

Whilst the first half of the current financial year delivered strong revenue growth due to contract wins with the NHS, the second half of the year has witnessed an increase in the number and value of new contracts from commercial customers. Of particular note are new contract wins at RWE, a top five European energy supplier, Achmea, the Netherlands leading insurance company and BTG, a growing international specialist healthcare company worth a combined value of approximately £500k.

 

Strengthening of Management and Sales Teams

The integration of Pentana is now complete and the Group has made a number of non-board management changes. Ken Ebbage, formerly Chief Executive of Pentana, has been appointed Managing Director, Product and Services for the Group's Risk and Compliance business and Terry Perkins, formerly Services Director of Pentana, has been appointed Product Director for Risk and Compliance. In addition, the company has recruited additional sales resource into the commercial team in order to capture the growing opportunity within this market segment.

 

Outlook

The Company expects the rest of the second half of the current financial year to benefit from the continued increase in commercial activities in addition to further NHS contract wins. In particular, Guys and St Thomas' NHS foundation trust is now the Group's latest NHS customer and we expect to announce further significant NHS contracts over the next two months.

 

David Hornsby, Chief Executive, commented: "I am delighted with progress so far in the second half. We are seeing increased momentum in our commercial business and the NHS remains a strong market for the Group. I am particularly pleased with the rapid integration of Pentana into the Group which has provided a great platform for profitable growth.

 

The Company therefore continues to trade in line with market expectations and looks forward to providing a further update in May following the end of the current financial period."

 

Enquiries:

 

 

 

Ideagen Plc

 

Tel: 01629 699100

David Hornsby, Chief Executive

 

 

Graeme Spenceley, Finance Director

 

 

finnCap (Nominated Adviser and Broker)

 

Tel: 020 7220 0500

Matt Goode, Charlotte Stranner,

Ben Thompson (Corporate Finance)

 

 

Stephen Norcross (Corporate Broking)

 

 

Walbrook PR Ltd

 

Tel: 020 7933 8780

Helen Cresswell

 

Helen.cresswell@walbrookpr.com

Paul Cornelius

 

Paul.cornelius@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSSFADFLSEED
Date   Source Headline
8th Jul 20227:00 amRNSCancellation - Ideagen Plc
8th Jul 20227:00 amBUSForm 8.3 - Ideagen PLC
7th Jul 20223:45 pmRNSHolding(s) in Company
7th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
7th Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
7th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
7th Jul 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
7th Jul 20221:19 pmGNWForm 8.3 - Ideagen PLC
7th Jul 202211:21 amRNSForm 8.3 - Ideagen plc
7th Jul 202210:39 amRNSForm 8.5 (EPT/RI)
7th Jul 20229:08 amRNSForm 8.5 (EPT/RI) - Ideagen Plc
7th Jul 20227:30 amRNSSuspension – Ideagen PLC
7th Jul 20227:00 amRNSHolding(s) in Company
7th Jul 20227:00 amRNSScheme becomes Effective
6th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
6th Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
6th Jul 20223:10 pmRNSHolding(s) in Company
6th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
6th Jul 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
6th Jul 202211:41 amRNSForm 8.5 (EPT/RI)
6th Jul 202211:08 amGNWForm 8.3 - [IDEAGEN PLC - 05 07 2022] - (CGWL)
6th Jul 202211:03 amRNSForm 8.3 - IDEAGEN PLC
6th Jul 20229:09 amRNSForm 8.5 (EPT/RI) - Ideagen Plc
6th Jul 20229:00 amRNSForm 8 (DD) - Ideagen plc
6th Jul 20229:00 amRNSForm 8 (DD) - Ideagen plc
6th Jul 20227:00 amBUSForm 8.3 - Ideagen PLC
5th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
5th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
5th Jul 20222:30 pmRNSExercise of Options, Issue of Equity and Rule 2.9
5th Jul 20222:20 pmRNSCourt Sanction of Scheme of Arrangement
5th Jul 202212:24 pmGNWForm 8.3 - [IDEAGEN PLC 04 07 2022] - (CGWL)
5th Jul 202212:13 pmRNSDisclosure under Rule 26
5th Jul 202212:10 pmRNSForm 8.3 - Ideagen plc
5th Jul 202210:58 amRNSForm 8.5 (EPT/RI)
5th Jul 20228:13 amRNSForm 8.5 (EPT/RI)
4th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
4th Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
4th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
4th Jul 20222:30 pmRNSHolding(s) in Company
4th Jul 202212:07 pmRNSForm 8.3 - Ideagen plc
4th Jul 202210:55 amRNSForm 8.5 (EPT/RI)
4th Jul 202210:47 amGNWForm 8.3 - [IDEAGEN PLC - 01 07 2022] - (CGWL)
4th Jul 20227:00 amBUSForm 8.3 - Ideagen PLC
1st Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
1st Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
1st Jul 20223:11 pmGNWForm 8.3 - [Ideagen plc - 30 06 2022] - (CGWL)
1st Jul 20223:09 pmRNSForm 8.3 - Ideagen plc
1st Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
1st Jul 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
1st Jul 202212:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.